Oric Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Oric Pharmaceuticals, Inc. has filed 412 SEC EDGAR filings since 13 Dec 2019

SEC filing history

Showing 201-225 of 412 matching filings.

Per page
25
Current page
9
S-8 File 333-270619

S-8

Filing date
16 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A SUBMISSION

Filing date
17 Feb 2023
Reporting date
15 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A SUBMISSION

Filing date
17 Feb 2023
Reporting date
15 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A SUBMISSION

Filing date
17 Feb 2023
Reporting date
15 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91490

SC 13G/A filing

Filing date
13 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91490

SC 13G/A filing

Filing date
10 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91490

SC 13G/A filing

Filing date
09 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91490

SC 13G/A filing

Filing date
06 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Feb 2023
Reporting date
01 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Feb 2023
Reporting date
01 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Feb 2023
Reporting date
01 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91490

SC 13G filing

Filing date
20 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91490

SC 13G ORIC PHARMACEUTICALS

Filing date
29 Dec 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
29 Dec 2022
Reporting date
23 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91490

AMENDMENT NO. 4

Filing date
27 Dec 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-255833

424B5

Filing date
21 Dec 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Dec 2022
Reporting date
15 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Dec 2022
Reporting date
15 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Dec 2022
Reporting date
15 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .